Celltrion
068270.KS
#724
Rank
HK$212.26 B
Marketcap
HK$1,036
Share price
0.05%
Change (1 day)
-8.36%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$19.44 Billion

According to Celltrion 's latest financial reports the company's total liabilities are HK$19.44 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31HK$10.02 B-5.81%
2021-12-31HK$10.64 B-6.36%
2020-12-31HK$11.36 B70.99%
2019-12-31HK$6.64 B4.35%
2018-12-31HK$6.36 B-1.65%
2017-12-31HK$6.47 B22.32%
2016-12-31HK$5.29 B-14.44%
2015-12-31HK$6.18 B-10.35%
2014-12-31HK$6.90 B5.27%
2013-12-31HK$6.55 B28.6%
2012-12-31HK$5.09 B49.87%
2011-12-31HK$3.40 B31.17%
2010-12-31HK$2.59 B40.74%
2009-12-31HK$1.84 B5.95%
2008-12-31HK$1.73 B492.51%
2007-12-31HK$0.29 B